---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-013553"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:18:52.179265+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Strata Critical Medical Q4 revenue up 83.5% YoY to $66.8M; raises FY2026 guidance

## Summary
- Q4 2025 revenue $66.8M (+83.5% YoY); logistics revenue up 35.3% to $49.2M.
- Full year 2025 revenue $197.1M, Adjusted EBITDA $14.1M, both above guidance high end.
- Full year 2025 net loss from continuing ops $20.1M vs $16.1M in 2024.
- FY2026 revenue guidance raised to $260-275M; Adjusted EBITDA guidance raised to $29-33M.
- Clinical segment (Keystone) contributed $17.6M revenue in Q4; total gross profit $14.4M.

## SEC filing metadata
- accession: 0001628280-26-013553
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/0001628280-26-013553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/srta-20260303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-013553
- JSON: https://secwatch.observer/filing/0001628280-26-013553.json
- Plain text: https://secwatch.observer/filing/0001628280-26-013553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.